Abstract
This chapter discussed how neuroendocrine findings in posttraumatic stress disorder (PTSD) potentially inform hypothalamic-pituitary-adrenal (HPA) alterations in PTSD and highlight alterations relevant to the identification of targets for drug development. Most studies demonstrate alterations consistent with an enhanced negative feedback inhibition of cortisol on the pituitary, an overall hyperreactivity of other target tissues (adrenal gland, hypothalamus), or both in PTSD. However, findings of low cortisol and increased reactivity of the pituitary in PTSD are also consistent with reduced adrenal output. The observations in PTSD are part of a growing body of neuroendocrine data providing evidence of insufficient glucocorticoid signaling in stress-related neuropsychiatric disorders.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
References
Aardal-Eriksson E, Eriksson TE, Thorell L (2001) Salivary cortisol, posttraumatic stress symptoms and general health in the acute phase and during 9-month follow-up. Biol Psychiatry 50:986–993
Altemus M, Cloitre M, Dhabhar FR (2003) Enhanced cellular immune responses in women with PTSD related to childhood abuse. Am J Psychiatry 160:1705–1707
Anisman H, Griffiths J, Matheson K, Ravindran AV, Merali Z (2001) Posttraumatic stress symptoms and salivary cortisol levels. Am J Psychiatry 158:1509–1511
Atmaca M, Kuloglu M, Tezcan E, Onal S, Ustundag B (2002) Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder. Eur Arch Psychiatry Clin Neurosci 252:161–165
Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti TD Jr (1999) Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder [published erratum appears in Am J Psychiatry 1999 Jun;156(6):986]. Am J Psychiatry 156:585–588
Bonne O, Brandes D, Segman R, Pitman RK, Yehuda R, Shalev AY (2003a) Prospective evaluation of plasma cortisol in recent trauma survivors with posttraumatic stress disorder. Psychiatry Res 119:171–175
Bonne O, Gilboa A, Louzoun Y, Brandes D, Yona I, Lester H, Barkai G, Freedman N, Chisin R, Shalev AY (2003b) Resting regional cerebral perfusion in recent posttraumatic stress disorder. Biol Psychiatry 54:1077–1086
Boscarino JA (1996) Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: findings and clinical implications. J Consult Clin Psychol 64:191–201
Bourne PG, Rose RM, Mason JW (1968) 17 OHCS levels in combat. Special forces “A” team under threat of attack. Arch Gen Psychiatry 17:104–110
Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS (1997) Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 154:624–629
Bremner JD, Vythilingma M, Vermetten E, Adil J, Khan S, Nazeer A, Afzal N, McGlashan T, Elzinga B, Anderson GM, Heninger G, Southwick SM, Charney DS (2003a) Cortisol response to a cognitive stress challenge in posttraumatic stress disorder related to childhood abuse. Psychoneuroendocrinology 28:733–750
Bremner JD, Vythilingam M, Anderson G, Vermetten E, McGlashan T, Heninger G, Rasmusson A, Southwick SM, Charney DS (2003b) Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol Psychiatry 54:710–718
Carrion VG, Weems CF, Ray RD, Glaser B, Hessl D, Reiss AL (2002) Diurnal salivary cortisol in pediatric posttraumatic stress disorder. Biol Psychiatry 51:575–582
Coupland NJ, Hegadoren KM, Myrholm J (2003) Increased beclomethasone-induced vasoconstriction in women with posttraumatic stress disorder. J Psychiatr Res 37:221–228
DeBellis MD, Chrousos GP, Dorn LD, Burke L, Helmers K, Kling MA, Trickett PK, Putnam FW (1994) Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. JClin Endocrinol Metab 78:249–255
De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, Jenkins FJ, Ryan ND (1999) A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems [see comments]. Biol Psychiatry 45:1259–1270
de Kloet ER, Joels M, Oitzl M, Sutanto W (1991) Implication of brain corticosteroid receptor diversity for the adaptation syndrome concept. Methods Achiev Exp Pathol 14:104–132
Delahanty DL, Raimonde AJ, Spoonster E (2000) Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol Psychiatry 48:940–947
Dinan TG, Barry S, Yatham LN, Mobayed M, Brown I (1990) A pilot study of a neuroendocrine test battery in posttraumatic stress disorder. Biol Psychiatry 28:665–672
Elzinga BM, Schmahl CG, Vermetten E, van Dyck R, Bremner JD (2003) Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology 28:1656–1665
Glover D, Poland R (2002) Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology 27:805–819
Goeinjian AK, Pynoos RS, Steinberg Am, Endres D, Abraham K, Geffner ME, Fairbanks LA (2003) Hypothalamic-pituitary-adrenal activity among Armenian adolescents with PTSD symptoms. J Trauma Stress 16:319–323
Goenjian AK, Yehuda R, Pynoos RS, Steinberg AM, Tashjian M, Yang RK, Najarian LM, Fairbanks LA (1996) Basal cortisol, dexamethasone suppression of cortisol and MHPG in adolescents after the 1988 earthquake in Armenia. Am J Psychiatry 153:929–934
Gormley GJ, Lowy MT, Reder AT, Hospelhorn VD, Antel JP, Meltzer HY (1985) Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am J Psychiatry 142:1278–1284
Gotovak K, Sabioncello A, Rabatic S, Berki T, Dekaris D (2003) Flow cytometric determination of glucocorticoid receptor expression in lymphocyte subpopulations: lower quantity of glucocorticoid receptors in patients with posttraumatic stress disorder. Clin Exp Immunol 131:335–339
Grossman R, Yehuda R, New A, Schmeidler J, Silverman J, Mitropoulous V, Sta Maria N, Bgolier J, Siever L (2003) Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression. Am J Psychiatry 160:1291–1298
Halbreich U, Olympia J, Carson S, Glogowski J, Yeh CM, Axelrod S, Desu MM (1989) Hypothalamo-pituitary-adrenal activity in endogenously depressed posttraumatic stress disorder patients. Psychoneuroendocrinology 14;:365–370
Hawk LW, Dougall AL, Ursano RJ, Baum A (2000) Urinary catecholamines and cortisol in recent-onset posttraumatic stress disorder after motor vehicle accidents. Psychosom Med 62:423–434
Heim C, Newport JJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CG (2000) Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284:592–597
Heim C, Ehlert U, Rexhausen J, Hanker JP, Hellhammer DH (1998) Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med 60:309–318
Heim C, Ehlert U, Hellhammer DH (2000) The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25:1–35
Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB (2001) Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 158:575–581
Hockings GI, Grice JE, Ward WK, Walters MM, Jensen GR, Jackson RV (1993) Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in posttraumatic stress disorder. Biol Psychiatry 33:585–593
Hoffmann L, Burges Watson P, Wilson G, Montgomery J (1989) Low plasma b-endorphin in posttraumatic stress disorder. Aust NZ J Psychiatry 23:269–273
Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501
Holsboer F, Lauer CJ, Schreiber W, Krieg JC (1995) Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62:340–347
Hucklebridge FH, Clow A, Abeyguneratne T, Huezo-Diaz P, Evans P (1999) The awakening cortisol response and blood glucose levels. Life Sci 64:931–937
Jensen CF, Keller TW, Peskind ER, McFall ME, Veith RC, Martin D, Wilkinson CW, Raskind M (1997) Behavioral and neuroendocrine responses to sodium lactate infusion in subjects with posttraumatic stress disorder. Am J Psychiatry 154:266–268
Kanter ED, Wilkinson CW, Radant AD, Petrie EC, Dobie DJ, McFall ME, Peskind ER, Raskind MA (2001) Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol Psychiatry 50:238–245
Kauffman J, Birmaher B, Perel J, Dahl RE, Moreci P, Nelson B, Wells W, Ryan ND (1997) The corticotrophin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Biol Psychiatry 42:669–679
Kellner M, Baker DG, Yehuda R (1997) Salivary cortisol in Operation Desert Storm returnees. Biol Psychiatry 42:849–850
Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, Yehuda R (2000) Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biol Psychiatry 47:107–111
Kellner M, Baker DG, Yassouridis A, Bettinger S, Otte C, Naber D, Wiedemann K (2002a) Mineralocorticoid receptor function in patients with posttraumatic stress disorder. Am J Psychiatry 159:1938–1940
Kellner M, Yehuda R, Arlt J, Wiedemann K (2002b) Longitudinal course of salivary cortisol in posttraumatic stress disorder. Acta Psychiatr Scand 105:153–155
King JA, Mandansky D, King S, Fletcher KE, Brewer J (2001) Early sexual abuse and low cortisol. Psychiatry Clin Neurosci 55:71–74
Kosten TR, Wahby V, Giller E, Mason J (1990) The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder. Biol Psychiatry 28:657–664
Krishnan KRR, Rayasam K, Reed D, Smith M, Chapell P, Saunders WB, Ritchie JC, Carroll BJ, Nemeroff CB (1993) The corticotropin releasing factor stimulation test in patients with major depression: relationship to dexamethasone suppression test results. Depression 1:133–136
Kudler H, Davidson J, Meador K, Lipper S, Ely T (1987) The DST and posttraumatic stress disorder. Am J Psychiatry 14:1058–1071
Lemieux AM, Coe CL (1995) Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med 57:105–115
Liberzon I, Abelson JL, Flagel SB, Raz J, Young EA (1999) Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 21:40–50
Lipschitz DS, Rasmusson AM, Yehuda R, Wang S, Anyan W, Gueoguieva R, Grilo CM, Fehon DC, Southwick SM (2003) Salivary cortisol response to dexamethasone in adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 42:1310–1317
Lowy MT (1989) Quantification of type I and II adrenal steroid receptors in neuronal, lymphoid and pituitary tissues. Brain Res 503:191–197
Luecken LJ, Dausche B, Gulla V, Hong R, Compas BE (2004) Alterations inmorning cortisol associated with PTSD in women with breast cancer. J Psychosom Res 56:13–15
Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, Biondi M, Bosmans E, Kenis G, Scharpe S (1998) Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 98:328–335
Mason JW, Giller EL, Kosten TR, Ostroff RB, Podd L (1986) Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis 174:145–159
Mason JW, Wang S, Yehuda R, Riney S, Charney DS, Southwick SM (2001) Psychogenic lowering of urinary cortisol levels linked to increased emotional numbing and a shame-depressive syndrome in combat-related posttraumatic stress disorder. Psychosom Med 63:387–401
McEwen BS, Seeman T (1999) Protective and damaging effects of mediators of stress: elaborating and testing the concepts of allostasis and allostatic load. Ann NY Acad Sci 896:30–47
Newport DJ, Heim C, Bonsall R, Miller AH, Nemeroff CB (2004) Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 55:10–20
Neylan TC, Lenoci M, Maglione ML, Rosenlicht NZ, Metlzer TJ, Otte C, Schoenfeld FB, Yehuda R, Marmar CR (2003a) Delta sleep response to metyrapone in posttraumatic stress disorder. Neuropsychopharmacology 28:1666–1676
Neylan TC, Schuff N, Lenoci M, Yehuda R, Weiner MW, Marmar CR (2003b) Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry 54:1118–1121
Oquendo MA, Echavarria G, Galfalvy HC, Grunebaum MF, Burke A, Barrera A, Cooper TB, Malone KM, Mann JJ (2003) Lower cortisol levels in depressed patients with comorbid posttraumatic stress disorder. Neuropsychopharmacology 28:591–598
Pitman RK, Orr SP (1990) Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol Psychiatry 27:245–247
Raison CL, Miller AH (2003) When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress related disorders. Am J Psychiatry 160:1554–1565
Rasmusson AM, Lipschitz DS, Wang S, Hu S, Vojvoda D, Bremner JD, Southwick SM, Charney D (2001) Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry 12:965–977
Reist C, Kauffmann ED, Chicz-Demet A, Chen CC, Demet EM (1995) REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 19:433–443
Resnick HS, Yehuda R, Pitman RK, Foy DW (1995) Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry 152:1675–1677
Ribeiro SC, Tandon R, Grunhaus L, Greden JF (1993) The DST as a predictor of outcome in depression: a meta-analysis [see comments]. Am J Psychiatry 150:1618–1629
Rinne T, deKloet ER, Wouters L, Goekoop JG, DeRijk RH, van de Brink W (2002) Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry 52:1102–1112
Sapolsky RM, Krey LC, McEwen BS (1984) Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 114:287–292
Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284–301
Sautter FJ, Bisette G, Wiley J, Manguno-Mire G, Schoenbachler B, Myers L, Johnson JE, Cerbone A, Malaspina D (2003) Corticotropin-releasing factor in posttraumatic stress disorder with secondary psychotic symptoms, nonpsychotic PTSD, and health control subjects. Biol Psychiatry 54:1382–1388
Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhausler HB, Kapfhammer HP (2001) The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol Psychiatry 50:978–985
Schulte HM, Chrousos GP, Avgerinos P, Oldfield EH, Gold PW, Cutler GB, Loriaux DL (1984) The corticotrophin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. J Clin Endocrinol metab 58:1064–1067
Seedat S, Stein MB, Kennedy CM, Hauger RL (2003) Plasma cortisol and neuropeptide Y in female victims of intimate partner violence. Psychoneuroendocrinology 28:796–808
Smith MA, Davidson J, Ritchie JC, Kudler H, Lipper S, Chappell P, Nemeroff CB (1989) The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry 26:349–355
Stein MB, Yehuda R, Koverola C, Hanna C (1997) Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry 42:680–686
Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E (1984) Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry 41:257–267
Svec F (1985) Glucocorticoid receptor regulation. Life Sci 36:2359–2366
Thaller V, Vrkljan M, Hotujac L, Thakore J (1999) The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis. Coll Antropol 23:611–619
Wang S, Wilson JP, Mason JWL (1996) Stages of decompensation in combat-related posttraumatic stress disorder: a new conceptual model. Integr Physiol Behav Sci 31:237–253
Yehud R, Hallig SL, Grossman R (2001) Childhood trauma and risk for PTSD: relationship to intergenerational effects of trauma, parental PTSD, and cortisol excretion. Dev Psychopathol 13:733–753
Yehuda R (1999a) Risk factors for posttraumatic stress disorder. American Psychiatric Press, Washington
Yehuda R (1999b) Biological factors associated with susceptibility to posttraumatic stress disorder. Can J Psychiatry 44:34–39
Yehuda R (2002) Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am 25:341–368
Yehuda R, Nemeroff CB (1994) Neuropeptide alterations in affective and anxiety disorders. In: DenBoer JA, Sisten A (eds) Handbook on depression and anxiety: a biological approach. Marcel Dekker, New York, pp 543–571
Yehuda R, Southwick SM, Nussbaum G, Wahby V, Giller EL, Mason JW (1990) Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis 178:366–369
Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW (1991a) Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 30:1031–1048
Yehuda R, Lowy MT, Southwick S, Shaffer D, Giller EL (1991b) Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am J Psychiatry 148:499–504
Yehuda R, Boisoneau D, Mason JW, Giller EL (1993a) Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry 34:18–25
Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW (1993b) Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 150:83–86
Yehuda R, Boisoneau D, Lowy MT, Giller EL (1995a) Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 52:583–593
Yehuda R, Kahana B, Binder-Brynes K, Southwick S, Mason JW, Giller EL (1995b) Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry 152:982–986
Yehuda R, Levengood RA, Schmeidler J, Wilson S, Guo LS, Gerber D (1996a) Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology 21:1–16
Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ (1996b) Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 40:79–88
Yehuda R, Bierer LM, Schmeidler J, Aferiat DH, Breslau I, Dolan S (2000) Low cortisol and risk for PTSD in adult offspring of holocaust survivors. Am J Psychiatry 157:1252–1259
Yehuda R, Halligan S, Grossman R (2001) Childhood trauma and risk for PTSD: relationship to intergenerational effects of trauma, parental PTSD and cortisol excretion. Stress Dev 13:731–751
Yehuda R, Halligan SL, Bierer LM (2002a) Cortisol levels in adult offspring of Holocaust survivors: relation to PTSD symptom severity in the parent and child. Psychoneuroendocrinology 27:171–180
Yehuda R, Halligan SL, Grossman R, Golier JA, Wong C (2002b) The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol Psychiatry 52:393–403
Yehuda R, Golier J, Yang RK, Tischler L (2004a) Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol Psychiatry 55:1110–1116
Yehuda R, Halligan SL, Golier J, Grossman R, Bierer LM (2004b) Effects of trauma exposure on the cortisol response to dexamethasone administration in TPSD and major depressive disorder. Psychoneuroendocrinology 29:389–404
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Yehuda, R. (2005). Neuroendocrine Aspects of PTSD. In: Holsboer, F., Ströhle, A. (eds) Anxiety and Anxiolytic Drugs. Handbook of Experimental Pharmacology, vol 169. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28082-0_13
Download citation
DOI: https://doi.org/10.1007/3-540-28082-0_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22568-3
Online ISBN: 978-3-540-28082-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)